BetterScholar BetterScholar
7
Role
Title
Level Year L/R
🐜 Influence of Low-Dose Ritonavir With and Without Darunavir on the Pharmacokinetics and Pharmacodynamics of Inhaled Beclomethasone
10 auth. S. Boyd, C. Hadigan, Maryellen Mcmanus, Cheryl L. Chairez, L. Nieman, A. Pau, ... R. Alfaro, J. Kovacs, M. M. Calderon, S. Penzak
6 2013
6
🐜
🐜 Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug–Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine
14 auth. Kristina M. Brooks, Jomy M. George, A. Pau, Adam W. Rupert, C. Mehaffy, Prithwiraj De, K. Dobos, Anela Kellogg, M. McLaughlin, Maryellen Mcmanus, ... R. Alfaro, C. Hadigan, J. Kovacs, Parag Kumar
5 2018
5
🐜
🐜 Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P-Glycoprotein Transport and the Pharmacokinetic/Pharmacodynamic Disposition of Dabigatran
11 auth. Parag Kumar, L. A. Gordon, Kristina M. Brooks, Jomy M. George, Anela Kellogg, Maryellen Mcmanus, ... R. Alfaro, Khanh Nghiem, J. Lozier, C. Hadigan, S. Penzak
5 2017
5
🐜
🐜 Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease.
23 auth. S. Kattakuzhy, E. Wilson, S. Sidharthan, Z. Sims, M. McLaughlin, A. Price, R. Silk, C. Gross, E. Akoth, Maryellen Mcmanus, ... B. Emmanuel, S. Shrivastava, Lydia Tang, Amy K. Nelson, Gebeyehu Teferi, J. Chavez, B. Lam, H. Mo, A. Osinusi, M. Polis, H. Masur, A. Kohli, S. Kottilil
4 2015
4
🐜
🐜 Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers.
11 auth. L. A. Gordon, Parag Kumar, Kristina M. Brooks, Anela Kellogg, Maryellen Mcmanus, R. Alfaro, ... Khanh Nghiem, Jomy M. George, J. Lozier, S. Penzak, C. Hadigan
4 2016
4
🐜
🐜 Pioglitazone for Hepatic Steatosis in HIV/Hepatitis C Virus Coinfection.
10 auth. Lindsay A Matthews, D. Kleiner, Cheryl L. Chairez, Maryellen Mcmanus, Mary Jane Nettles, Kira Zemanick, ... C. Morse, D. Benator, J. Kovacs, C. Hadigan
3 2015
3
🐜
🐜 1413. A Phase IIa Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of Encochleated Amphotericin B in Patients with Mucocutaneous (Esophogeal, Oropharyngeal, Vulvovaginal) Candidiasis Who are Refractory or Intolerant to Standard Non-Intravenous Therapies
12 auth. Lilian W. Kibathi, Parag Kumar, M. Lionakis, A. Urban, Elise M. N. FerrΓ©, Maryellen Mcmanus, ... Benjamin Colton, C. Lambros, R. Lu, R. Mannino, E. Tramont, A. Freeman
3 2018
3
🐜